Chevilly-Larue, France

Claude Bensoussan


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claude Bensoussan: Innovator in Pharmaceutical Chemistry

Introduction

Claude Bensoussan is a notable inventor based in Chevilly-Larue, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of cyclosporin derivatives. His work has implications for the treatment of retrovirus infections, showcasing the importance of innovation in medical science.

Latest Patents

Bensoussan holds a patent for "Cyclosporin derivatives, their preparation and the pharmaceutical." This patent details cyclosporin derivatives of formula (I), where R is H or a radical (Ia) or (Ib) as defined herein. Additionally, R' is a radical (Ic) or (Id) as defined herein, and R' represents H or OH, with the stipulation that R and R' are not simultaneously H. The patent also discusses pharmaceutically acceptable salts that are useful for the treatment and/or prophylaxis of retrovirus infections. He has 1 patent to his name.

Career Highlights

Claude Bensoussan has had a distinguished career, working with Rhone-Poulenc Rorer S.A. His expertise in pharmaceutical chemistry has allowed him to contribute to significant advancements in the field. His innovative work continues to influence the development of new treatments.

Collaborations

Bensoussan has collaborated with notable colleagues, including Michel Evers and Serge Mignani. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in pharmaceutical research.

Conclusion

Claude Bensoussan's contributions to pharmaceutical chemistry, particularly through his patent on cyclosporin derivatives, highlight the vital role of inventors in advancing medical science. His work exemplifies the impact of innovation on healthcare and the ongoing quest for effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…